Skip to main content

Shiladitya Sengupta

NIH Rank #3895
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8527705Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$2.4M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#3,895
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Shiladitya Sengupta. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

NIBIB

National Institute of Biomedical Imaging and Bioengineering

$0

1 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Shiladitya Sengupta as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA293908-01R01
    Combinatorial application of nanoscale technologies to target a novel mechanism of immune evasion by cancer cells
    $690.8K
    award amount
  • 5R01EB035485-02R01
    Nanostructured degradable bone cement for delivering novel antibiotics
    $683.6K
    award amount
  • 5R01CA276525-02R01
    Tunneling Nanotube Inhibitors for Cancer Immunotherapy
    $620.5K
    award amount
  • 3R01CA276525-02S2R01
    Investigating nanotube-mediated mitochondria transfer and inhibitor effects in cancer-immune cell interactions across 2D and 3D models
    $259.6K
    award amount
  • 3R01CA276525-02S1R01
    Tunneling Nanotube Inhibitors for Cancer Immunotherapy
    $153.7K
    award amount

Award organization

Organizations that administered FY2024 awards listing Shiladitya Sengupta as a PI.

FY2024 award administered by Brigham and Women's Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3895
  6. 2024
    Entered Top 25% Nationally
    Ranked #3895
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Shiladitya Sengupta.